Location History:
- Ellicott, MD (US) (2019)
- Ellicott City, MD (US) (1999 - 2024)
- Gaithersburg, MD (US) (2019 - 2024)
Company Filing History:
36 out of 37 
14 out of 3,539 
7 out of 3,687 
Years Active: 1999-2025
Areas of Expertise:
Title: Inventor Spotlight: Boro Dropulic Revolutionizing Cancer Treatment
Introduction:
Boro Dropulic, a distinguished inventor based in Ellicott City, MD, has made significant contributions to the field of oncology with his groundbreaking patents and innovative research in cancer treatment.
Latest Patents:
Dropulic's latest patents showcase his cutting-edge approach to treating cancer. His inventions focus on utilizing chimeric antigen receptors to effectively target cancer cells. The patents detail novel compositions and methods for leveraging anti-mesothelin immunotherapy and self-driving chimeric antigen receptors in the fight against cancer.
Career Highlights:
With an impressive portfolio of 39 patents, Dropulic has demonstrated a deep commitment to advancing cancer therapies. Throughout his career, he has collaborated with renowned institutions and companies to translate his innovative ideas into tangible solutions for patients in need.
Collaborations:
Dropulic's collaborative spirit is evident through his work with esteemed colleagues such as Dina Schneider and Rimas J. Orentas. Together, they have spearheaded research initiatives that have the potential to reshape the landscape of cancer treatment.
Conclusion:
In conclusion, Boro Dropulic stands as a pioneering figure in the field of oncology, with a passion for innovation and a relentless drive to make a difference in the lives of those affected by cancer. His patents and collaborations underscore his commitment to pushing the boundaries of medical science and revolutionizing the way we approach cancer treatment.